RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 130 - per page Next page
Order by
euroPLX Introduces Tool to Overcome Reject vs. Accept Dilemma in Partnering
Simple online tool avoids counter-productive rejecting of meeting requests; doubtful requests are verified or withdrawn by requesting party. More
Genesis Conference on target to exceed all previous years
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Labtec´s sufentanil patch for chronic pain enters phase II in cooperation with hameln rds GmbH
Labtec GmbH, Langenfeld, Germany announces the start of the phase II clinical development program for its sufentanil transdermal patch. More
Novartis/Mitsubishi Tanabe Pharma’s Gilenia remains on track to achieve blockbuster sales in the Multiple Sclerosis Drug Market
The overall market for MS therapies will experience 3 percent annual growth from 2008 to 2018, according to findings from Decision Resources More
Satisfied with Stelara’s efficacy and dosing, nearly three-quarters of surveyed dermatologists will increase its use for the treatment of Psoriasis over the next year
Cost- and convenience-conscious physicians value dosage formulation and dosing frequency more than other segments, making them a target for emerging agents, according to a new report from Decision Resources More
JALEVA’S ‘NICOFIX’, A TRANSBUCCAL NICOTINE REPLACEMENT THERAPY PRODUCT, ACHIEVES OUTSTANDING TEST RESULTS
SAN DIEGO, CA, November 22, 2010 – Jaleva Pharmaceuticals LLC announces encouraging pre-clinical results for ‘NicoFix’, Jaleva’s proprietary Nicotine Replacement Therapy product currently under development.

BioTox Sciences has completed a pre-c More
HELM AG Acquires Shares in Amarin Technologies S.A.
Hamburg, December 10th, 2010

Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.

Amarin h More
A Hypertension drug requiring less-frequent dosing than Novartis’s Diovan/Tareg would earn similar patient share in Europe and U.S.
The fixed-dose combination Telmisartan/Amlodipine will become the new Decision Resources clinical gold standard for Hypertension in 2013 More
Studying heart failure of mice and men
Scientists at Robarts Research Institute, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure. More
APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") Announce Filing for Approval in Europe of Zolmitriptan Oral Dispersible Film (ODF)
APR, the drug developer and drug delivery technology provider headquartered in Balerna, Switzerland and its partner Labtec, the drug delivery technology developer headquartered in Langenfeld, Germany announce the submission of Zolmitriptan Oral Dispersibl More
Displaying 1..10 of 130 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Core banking strategies in European retail banking (Databook)
Dec 2007 - 18 pages - $1,295
Telecom's power shift to China hit IPO market in 2010
Feb 2011 - 4 pages - $100
SRM software investment in US manufacturing (Databook)
Jan 2007 - 10 pages - $1,295
SRM software investment in UK manufacturing (Databook)
Jan 2007 - 10 pages - $1,895
SP recovery on track: revenues up 4%, capex down 1% in 2010
Apr 2011 - 3 pages - $100
UK ITO and infrastructure services trends: 2010–13
May 2010 - 22 pages - $1,495
Generating loyalty - Customer and Supply Chain Analytics (Databook)
Dec 2006 - 17 pages - $1,295
SRM software investment in German manufacturing (Databook)
Jan 2007 - 10 pages - $1,895
SRM Software Investment in French Manufacturing (Databook)
Jan 2007 - 10 pages - $1,895
SRM Software Investment in Italian Manufacturing (Databook)
Jan 2007 - 10 pages - $1,895
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us